Статус неизвестен
Фаза I–II
Россия
MK - 3475; Suppressor of the PI3K/Akt pathways · Medical Research Council
Phase IIb Trial Evaluations Of The Effectiveness Of Treatment Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475 (Pembrolizumab)